It is a trading private limited company based in Cuttack, Orissa, India, established in 2007.
2007 | Cuttack, Orissa, India | Dormant Under Section 455Urence Pharma(India)Private Limited, a dormant under section 455 private limited company, was established on 30 April 2007 in Cuttack, Orissa, India. Engaging in other wholesale within the trade sector, it holds CIN: U51397OR2007PTC009308. Registered under ROC Roc Cuttack. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
Its leadership includes Jnanendra Samal (Director), Dharmendra Samal (Managing Director). Past directors included Saroj Sahoo, Satyaban Gahan, Narayan Satapathy. It holds no open charges and ₹2.30 M settled loans. Its latest AGM occurred on 29 September 2016, with the balance sheet filed on 31 March 2016. It is based at Kathagada Sahi,Choudhri Bazar, Cuttack, Orissa, 753002.
U51397OR2007PTC009308
009308
30 April 2007
₹0.50 M
₹0.50 M
Roc Cuttack
Unlisted
Dormant Under Section 455
Explore comprehensive insights into Urence Pharma(India)Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jnanendra Samal | Director | 30 Apr 2007 | Current |
| Dharmendra Samal | Managing Director | 10 Mar 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Aug 2008 | Past |
| Pramod Abcsdd | Director | 15 Mar 2011 | Past |
| Pramod Abcsdd | Managing Director | 15 Mar 2011 | Past |
| Pramod Abcsdd | Director | 15 Mar 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Urence Pharma(India)Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 67.74% decrease. The company also saw a substantial fall in profitability, with a 64.82% decrease in profit. The company's net worth Soared by an impressive increase of 113.67%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
In 2016, Urence Pharma(India)Private had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹2,300,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Dec 2008 | Syndicate Bank | ₹2.30 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Urence Pharma(India)Private, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Urence Pharma(India)Private, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Urence Pharma(India)Private's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Urence Pharma(India)Private Limited last Annual general meeting of members was held on 29 Sep 2016 as per latest MCA records. was documented.
Urence Pharma(India)Private Limited has filed its annual Financial statements for the year ended 31 Mar 2016 with Roc Cuttack. was recorded as a recent event.
The activity A charge registered on 10 Dec 2008 via Charge ID 10136175 with Syndicate Bank was fully satisfied on 17 Oct 2015. was completed.
Dharmendra Samal was appointed as a Managing Director was appointed as a Managing Director on 10 Mar 2011 & has been associated with this company since 14 years 8 months . was recorded as a recent event.
Progress on A charge with Syndicate Bank of Rs. 2.30 M registered on 10 Dec 2008 with Charge ID 10136175 was modified on 22 Jan 2010. was documented.
Progress on A charge with Syndicate Bank amounted to Rs. 2.30 M with Charge ID 10136175 was registered on 10 Dec 2008. was documented.
The CIN of Urence Pharma(India)Private Limited is U51397OR2007PTC009308.
Urence Pharma(India)Private Limited is headquartered at Kathagada Sahi,Choudhri Bazar, Cuttack, Orissa, 753002.
Urence Pharma(India)Private Limited was incorporated on 30 April 2007.
The current directors of Urence Pharma(India)Private Limited are
The primary industry of Urence Pharma(India)Private Limited is Trade.
Urence Pharma(India)Private Limited is unlisted.
The authorized capital of Urence Pharma(India)Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX